Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction

Brigitte C. Widemann

Research output: Contribution to journal › Article

Original languageEnglish (US)
Pages (from-to)1512-1513
Number of pages2
JournalPediatric Blood and Cancer
Volume62
Issue number9
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Fingerprint

Antineoplastic Antimetabolites
gamma-Glutamyl Hydrolase
Acute Kidney Injury
Methotrexate
Kidney

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Medicine(all)

Cite this

Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction. / Widemann, Brigitte C.

In: Pediatric Blood and Cancer, Vol. 62, No. 9, 01.09.2015, p. 1512-1513.

Research output: Contribution to journal › Article

Widemann, BC 2015, 'Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction', Pediatric Blood and Cancer, vol. 62, no. 9, pp. 1512-1513. https://doi.org/10.1002/pbc.25577
Widemann BC. Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction. Pediatric Blood and Cancer. 2015 Sep 1;62(9):1512-1513. https://doi.org/10.1002/pbc.25577
Widemann, Brigitte C. / Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction. In: Pediatric Blood and Cancer. 2015 ; Vol. 62, No. 9. pp. 1512-1513.
@article{4d64ef029953487093425529184ab1f3,
title = "Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction",
author = "Widemann, {Brigitte C.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/pbc.25577",
language = "English (US)",
volume = "62",
pages = "1512--1513",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction

AU - Widemann, Brigitte C.

PY - 2015/9/1

Y1 - 2015/9/1

UR - http://www.scopus.com/inward/record.url?scp=84938196347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938196347&partnerID=8YFLogxK

U2 - 10.1002/pbc.25577

DO - 10.1002/pbc.25577

M3 - Article

C2 - 25940351

AN - SCOPUS:84938196347

VL - 62

SP - 1512

EP - 1513

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 9

ER -

Access to Document